DataHow AG

Don’t miss Michael Sokolov and Angela Botros on stage at the Bioprocessing Summit Europe next week, from the 18th - 20th of March in Barcelona. A highlight on Tuesday is Angela's presentation which will showcase the integration of DataHowLab and BioNsight Cloud, made possible through our valued partnership with Eppendorf . This session will highlight the impact of an interconnected digital ecosystem and how digital bioprocessing comes to life. DataHow will take the stage in three key sessions throughout the event, reinforcing its role as a leading voice in next-generation bioprocessing and analytics: 🔹 Michael Sokolov - 18th March - How to Develop and What to Expect from Predictive Process Models Discover the strategies for developing accurate predictive models, the necessary inputs, and potential challenges. Based on industrial use cases, understand how these models can forecast performance, reduce variability, and streamline manufacturing, improving both efficiency and product quality in biologic drug development. 🔹Angela Botros - 18th March - Changing the Way of Process Development by Leveraging Hybrid Modeling. With DataHow's hybrid models, we examine the impact of process parameters on bioprocess profiles, optimizing cell culture, especially cardiomyocyte production. The BioNsight cloud and DataHowLab integration supports a seamless path from data creation to advanced analysis. 🔹Angela Botros (Moderator) - 19th March - Panel Discussion: AI and Big Data Tools in the Analytical Function and Beyond The panel discussion, moderated by Angela, will cover topics relating to the adoption of AI and Big Data tools. The discussion will cover success stories and failures of AI/ML initiatives, opportunities and challenges, comparisons against traditional approaches, and software tools, amongst others.   If you are at the conference, make sure to reach out to Michael and Angela. If you can’t make it but would like to hear more about any of the topics, just reach out to the team: https://lnkd.in/eqaWExMd #bioprocessingsummit #bioprocessing #Pharmainnovation #DataHow

Advance Your (Bio)Process Data Analytics Skills! 📊 Join the Spring 2025 Advanced Process Data Analytics Course by DataHow, running virtually over 6-half days from April 28th – May 7th, 2025. This course offers an in-depth exploration of data analytics and modeling methodologies for process data, tailored for scientists and engineers in the biopharma and process industries. The course scope includes: - Advanced analysis techniques for process data, - Introduction to multivariate data analysis, - Introduction to machine learning techniques and hybrid process modeling, - Model-based process understanding & optimization, - Application of techniques to industrial use cases, Learn from experts in their field about this increasingly critical domain through theory, brainstorming sessions, real-world case studies, and hands-on exercises with advanced analytics software. 🔗 Register now and level up your analytics game! https://lnkd.in/eFZu3WfC #DataAnalytics #Bioprocessing #DigitalBioprocessing #AI #ProfessionalGrowth #DataHow

Supporting our mission to advance digital bioprocessing, Moritz von Stosch and Kevin Healy will attend and present at IFPAC 2025, taking place next week in Washington D.C., from the 2nd to the 5th of March. On an action-packed Tuesday, they will deliver three insightful presentations that discuss the impact of our technologies and digital development methods, from both a scientific and commercial perspective. 🔹 Moritz von Stosch – Streamlining Bioprocess Development through Transfer Learning: A Novel Approach to Model Calibration and Experimental Design 🔹Kevin Healy – Economic Impacts of Digital Process Development and Optimization Strategies for Biopharmaceutical Manufacturing 🔹Moritz von Stosch – Hybrid Modeling-based Process Development in Cell Therapy, Gene Therapy, and mRNA Processes We look forward to engaging discussions on the future of bioprocessing and data-driven decision-making. If you're attending IFPAC, be sure to join these sessions and connect with them while they are there. #IFPAC2025 #Bioprocessing #BipharmaInnovation #DataHow

Last week, Michael Sokolov, Jakub Polak, and Riccardo De Luca from DataHow visited Centrient Pharmaceuticals in Barcelona to kick-off our collaboration to develop digital twins for process development and manufacturing. Thank you to Limber Acosta and his team for the warm welcome! We are excited to start this innovative project with the Centrient team and support you on your digital transformation journey. #DigitalTwins #Digitaltransformation #Bioprocessinnovation

🔍 New Case Study: Unlocking Gene Therapy with DataHowLab Gene therapy holds immense potential, but its development is constrained by high costs and the complexity of its multi-phase manufacturing process. To minimize costs, scientists work with limited experimental data, making the development of these processes even more challenging. Our latest case study explores how DataHowLab can help overcome these hurdles by enabling a cost effective, digital development approach. This approach enables: ✅ Accurate CQA prediction while requiring minimal experiments ✅ Insight into the impact of key process parameters on each CQA at every phase of production ✅ Transfer learning techniques to leverage historical data and reduce experimental burdens By applying advanced AI-enabled analytical technologies, DataHowLab is enabling a new efficient development path for gene therapies. 📖 Read the full case study here: https://lnkd.in/eMdF3_e7 #GeneTherapy #Bioprocessing #DigitalBioprocessing #AI #DataHow

Join us at the DataHow Symposium 2025! DataHows annual Symposium "Digital Bioprocessing – From Innovation to Impact," taking place June 25-26 at ETH Zurich is not to be missed for those interested in data driven, future focused bioprocessing. This event will bring together industry leaders, researchers, and innovators from many of the industry’s largest companies to explore how data-driven approaches, AI, and novel technologies, are transforming their organisations and bioprocess operations. Join us in Zurich for: 🔹 Inspiring presentations from domain experts 🔹 Insightful case studies from leading global organisations 🔹 Networking opportunities with industry peers & innovators Whether you're driving digital bioprocess transformation or looking to stay ahead of industry trends, this is an event you won’t want to miss! Early bird tickets available until March 15th! 📍 Register now: https://lnkd.in/ePczuFuZ #DataHowSymposium #Bioprocessing #Innovation #Digital #AI

Kevin Healy to speak at the Digital CMC Summit in Austin, Texas. At the summit, hosted by QbDVision, Kevin will share a presentation titled, “Streamlining Bioprocess Development through AI-Enabled Transfer Learning: Process Tech Transfer and Scale-up Leveraging Historical Process Data and Hybrid Modeling” His talk will discuss how: ✅ Transfer learning enhances technology transfer and scale-up by leveraging historical process data, ✅ How transfer learning improves predictive accuracy when scaling up, ✅ The role of hybrid modeling in streamlining bioprocess development, ✅ The impact of these advancements on agile decision-making and efficiency in pharmaceutical manufacturing. Meet him there to gain valuable insights into the future of smart, data-driven bioprocessing and understand how DataHow is supporting the industry move towards is digital future. 📍 Event Details: February 25th - 27th @ Austin, Texas https://lnkd.in/gJqRWQ7S #CMCSummit #Bioprocessing #AIinPharma #Digital #ScaleUp #QbD #DataHow

Industry Case Study: Accelerating Clone Selection with Transfer Learning 🚀 Clone selection is a critical, time-intensive step in biologics development. Scientists are tasked with identifying a single high-performing clone through extensive experimentation. But what if we could leverage historical data instead to make this process faster and more efficient? At DataHow, we apply transfer learning to streamline clone selection, reducing reliance on extensive experimental data. Our latest case study explores how our technologies unlock valuable insights from historical clones to accelerate new molecule development. Key Insights from the Case Study: ✅ Accelerating process design: Identifying top-performing clones using only standard condition data, supplemented with historical insights. ✅ Selecting the right historical data: Determining which historical clones contribute the most to predicting new clone behaviour. ✅ Early forecasting of leading clones: Using historical data to predict final clone performance, halving development time. By integrating transfer learning into the development workflows, we expect the industry to be able to reduce experimental workloads by half while continously building a knowledge base for future developments. Transform your historical data into valuable development asset. Read the full case study here: https://lnkd.in/ewK-G5AM #Biologics #CloneSelection #MachineLearning #TransferLearning #Bioprocessing #DataHow

Join us in Leiden on February 13th, for a day of open scientific dialogue at the Learn & Connect seminar. Next to Securecell AG and Getinge, we are proud co-hosts of this initiative which focuses on the impact of digital technologies, advanced data analytics, and automation on upstream bioprocessing. DataHow CIO, Moritz von Stosch, will be present alongside our partners to discuss how these new tools and technologies are shaping the future of bioprocessing. Meet him at the event by registering through the link below:https://lnkd.in/er59vNNx   #digitalization #bioprocessing #innovation #networking

Kevin Healy Joins DataHow as Chief Revenue Officer We are excited to announce the appointment of Kevin Healy as the new Chief Revenue Officer at DataHow! Kevin brings 30 years of experience in the pharmaceutical industry, spanning from early R&D to manufacturing scale, and brings a proven track record of rapidly scaling businesses and driving revenue growth. Over the past decade, he has helped companies adopt cutting-edge technologies to digitise and advance process knowledge, accelerate time-to-market, and ensure the highest standards of quality while reducing costs. "We're thrilled to have Kevin on board. I am confident his long-standing industry experience, and his passion and commitment to delivering value to the customer, will take us a step further in understanding their needs and challenges and ultimately help us to design, develop, and distribute better solutions.” - Alessandro Butte, CEO DataHow   Kevin's appointment, based out of the United States, also underlines DataHow’s commitment to its growing US customer base and to accelerating the adoption of DataHowLab in the US market and globally. Join us in welcoming Kevin to the team! We’re excited for the future and the impact his contributions will bring. #LeadershipAnnouncement #CRO #Welcome #Growth #DataHow